Viridian Therapeutics, Inc./DE Conversion of Stock, Shares Issued
Viridian Therapeutics, Inc./DE (VRDN) reported Conversion of Stock, Shares Issued of 2.93 million shares for the 0-month period ending 2014-06-17, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2014-11-14
- 2014-06-17: Conversion of Stock, Shares Issued 0 month 2.93M shares; Conversion of Stock, Shares Issued 2.93M shares.
| Period end | Conversion of Stock, Shares Issued 0 month | Conversion of Stock, Shares Issued |
|---|---|---|
| 2014-06-17 | 2.93M shares 10-Q · filed 2014-11-14 | 2.93M shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |